$BCTX presents strong preclinical data at SITC 2025: Bria-OTS+ rapidly activates both innate and adaptive immunity, producing potent, durable tumor-killing results. Lead programs Bria-BRES+ and Bria-PROS+ continue advancing.
https://globenewswire.com/news-release/2025/1...-2025.html